Logo - springer
Slogan - springer

Springer Healthcare | Ophthalmology and Therapy (Editorial Board)

Ophthalmology and Therapy

Ophthalmology and Therapy

ISSN: 2193-6528 (electronic version)

Journal no. 40123

Editors-in-Chief

Europe

Tariq Aslam, Manchester Royal Eye Hospital, Manchester, UK

USA

Terrence O’Brien, University of Miami, Miami, FL, USA

Editorial Board

Iqbal Ike K. Ahmed, University of Toronto, Canada
Jorge L. Alió, Vissum Instituto Oftalmologico de Alicante, Alicante, Spain
Renato Ambrósio Jr, Federal University of São Paulo, Brazil
Sanjay Asrani, Duke University Medical Center, Durham, NC, USA
José Cunha-Vaz, University of Coimbra, Coimbra, Portugal
Pedram Hamrah, Tufts Medical Center, Tufts University School of Medicine, Boston, MA, USA
Alon Harris, Indiana University School of Medicine, Indianapolis, IN, USA
Glen J. Jaffe, Duke University Medical Center, Durham, NC, USA
Peter K. Kaiser, Cole Eye Institute, Cleveland, OH, USA
Anselm Kampik, Ludwig-Maximilians-Universität München, Munich, Germany
Shigeru Kinoshita, Kyoto Prefectural University of Medicine, Kyoto, Japan
Eleni Nikita, Manchester Royal Eye Hospital, Manchester, UK
Praveen Patel, Moorfields Eye Hospital, London, UK
Giuseppe Querques, University Vita Salute, Milan, Italy
Srinivas R. Sadda, University of Southern California, Los Angeles, CA, USA
Jose-Alain Sahel, Institut de la Vision, Paris, France
Srilakshmi M Sharma, Johns Hopkins University, Baltimore, USA
David Steel, Sunderland Eye Infirmary, UK
Michael W. Stewart, Mayo School of Medicine, Jacksonville, USA
Clive Wilson, Strathclyde University, Glasgow, UK

Advisory Board

Dhanesh Amarnani, Ejaz Ansari, Pasquale Aragona, Ahmed Aref, Francesco Bandello, Noel Bauer, Roberto Bellucci, Kostas Boboridis, David Boyer, Irini Chatziralli, Jiaqi Chen, Jessica Ciralsky, Theodoros Empeslidis, Cesare Forlini, Stefano Gandolfi, Zisis Gatzioufas, Faruque Ghanchi, Shane Havens, Martina Herwig, Jean Pierre Hubschman, Amila Alikadic Husovic, Alexander Ionides, Mitchell Jackson, Soosan Jacob, Ingrida Januleviciene, Andreas Katsanos, Motoko Kawashima, George Kymionis, Scott Lawrence, Jacky Wai Yip Lee, Nikolas London, Norah Lincoff, Jodi Luchs, Habib Maged, Darlene Miller, Tatsuya Mimura, Majid Moshirfar, Cintia De Paiva, Henry Perry, Luciano Quaranta, Jullia A Rosdahl, Maria Teresa Sandinha, Richard Scawn, Karen Schaal, Silvana Schellini, Robert Sergott, Brent Alan Siesky, Rufino Silva, Ajay Singh, Sobha Sivaprasad, Divya Srikumaran, Amparo Navea Tejerina, Asheesh Tewari, Louis Tong, Nitin Verma, Stela Vujosevic, Hua-Tao Xie, Kunyong Xu, Pei Xu

For authors and editors

  • Aims and Scope

    Aims and Scope

    Close

    Ophthalmology and Therapy is an international, open access, peer-reviewed, rapid publication journal (peer review in 2 weeks, published 3–4 weeks from acceptance). The journal is dedicated to the publication of high-quality preclinical, clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of ophthalmological therapies, devices, and surgical techniques. Studies relating to diagnosis, pharmacoeconomics, public health, quality of life, and patient care, management, and education are also encouraged.

    The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, reviews, case reports, and short communications. The journal appeals to a global audience and receives submissions from all over the world. Articles published in Ophthalmology and Therapy may be accompanied by lay-level summaries, to assist patients (and caregivers) in understanding important medical advances.

    Moving forward from traditional publishing, Ophthalmology and Therapy offers a range of additional enhanced features designed to increase visibility, readership, and the educational value of the content. Each paper is accompanied by a bulleted Summary slide, giving a time-efficient overview of the content to a wide readership. Articles also have the option to include various other types of enhanced features including slide sets, videos and animations. All enhanced features are open access and are peer reviewed to the same high standard as the article itself.

    Ophthalmology and Therapy is published under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, click here: http://creativecommons.org/licenses/by-nc/4.0.

    Upon acceptance of your article for publication, you will be required to pay the article processing charge of £250/ €340/ $380 per printed page. This will enable you to keep the copyright; you are simply assigning the exclusive right to any commercial use of the article to Springer. Your article will be immediately and permanently available with open access. The journal will consider fee discounts for developing countries and this is decided on a case by case basis.

    Peer Review Process

    Upon submission, manuscripts are assessed by the editorial team to ensure they fit within the aims and scope of the journal and are also checked for plagiarism. All suitable submissions are then subject to a comprehensive double-blind peer review. Reviewers are selected based on their relevant expertise and publication history in the subject area. The journal has an extensive pool of editorial and advisory board members who have been selected to assist with peer review based on the afore-mentioned criteria.

    At least two extensive reviews are required to make the editorial decision. Where reviewer recommendations are conflicted, the editorial board will be contacted for further advice and a presiding decision. Manuscripts are then either accepted, rejected or authors are required to make major or minor revisions (both reviewer comments and editorial comments may need to be addressed). Once a revised manuscript is re-submitted, it is assessed along with the responses to reviewer comments and if it has been adequately revised it will be accepted for publication. Accepted manuscripts are then copyedited and typeset by the production team before online publication.

    For more information about the journal, please contact christopher.vautrinot@springer.com.

  • Submit Online
  • Instructions for Authors (pdf, 1.1 MB)
  • Author Disclosure form (pdf, 131 kB)
  • Compliance with Ethical Policies
  • Author Academy: Training for Authors
  • Copyright Information

    Copyright Information

    Close

    Copyright Information

    Open Access Ophthalmology and Therapy is published under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, click here: http://creativecommons.org/licenses/by-nc/4.0

    Journal ownership: Springer Healthcare

    Copyright of articles: © The Author(s)

Alerts for this journal

 

Get the table of contents of every new issue published in Ophthalmology and Therapy.